Ticker

SARASOTA, Fla., March 05, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced the adoption of time-lapse incubation technology at its Wisconsin clinic.

INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach INVO's Wisconsin Clinic is now in-network for Progyny members, expanding the clinic's market reach

SARASOTA, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it has successfully closed the previously announced acquisition of Family Beginnings, P.C.

New patent extends intellectual property protection on the Company's INVOcell device through 2040 New patent extends intellectual property protection on the Company's INVOcell device through 2040

INVO Fertility (NASDAQ: IVF - Get Free Report) and Minerva Surgical (NASDAQ: UTRS - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations. Institutional and Insider Ownership 12.0% of INVO